RIBAVIRIN (Zydus Pharmaceuticals USA Inc.)
Welcome to the PulseAid listing for the RIBAVIRIN drug offered from Zydus Pharmaceuticals USA Inc.. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Zydus Pharmaceuticals USA Inc. |
| NON-PROPRIETARY NAME: | ribavirin |
| SUBSTANCE NAME: | RIBAVIRIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-12-15 |
| END MARKETING DATE: | 0000-00-00 |
RIBAVIRIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | RIBAVIRIN from Zydus Pharmaceuticals USA Inc. |
| LABELER NAME: | Zydus Pharmaceuticals USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6(g/1) |
| START MARKETING DATE: | 2016-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68382-395_b5083151-5726-482f-83e9-865f245eacc5 |
| PRODUCT NDC: | 68382-395 |
| APPLICATION NUMBER: | ANDA207366 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers:
